Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
Stephen J. FreedlandRecruiting - Northwestern University
Chicago, Illinois, United States
Ashley E. RossRecruiting - University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Abhinav SidanaRecruiting - Duke University Medical Center
Durham, North Carolina, United States
Judd W. MoulRecruiting - University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
David F. JarrardRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Sept 2024
- Primary completion
- 1 Nov 2026
- Completion
- 1 May 2027
- Last update posted
- 13 May 2026
- Registered enrollment
- 90
- Registry id
- NCT06022822
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.